Dr. Reddy’s Laboratories broke out from a 5-week consolidation in September 2025, signaling a potential rally. Experts suggest short-term traders consider buying with a target of Rs 1,360 within 1-2 months. The stock, supported by encouraging volumes, faces immediate resistance around Rs 1,320–1,340, with strong support expected at Rs 1,260–1,240.
